Showing results (1-10 of 59) with videos related to

Sort By:
Pageof 6
Neuroendocrinology|February 21, 2012
Signaling pathways as specific pharmacologic targets for neuroendocrine tumor therapy: RET, PI3K, MEK, growth factors, and NotchYvette Carter, Renata Jaskula-Sztul, Herbert Chen, et al.
Annals of Surgical Oncology|June 20, 2008
Suberoyl bishydroxamic acid activates notch1 signaling and suppresses tumor progression in an animal model of medullary thyroid carcinomaLi Ning, Renata Jaskula-Sztul, Muthusamy Kunnimalaiyaan, et al.
Frontiers in Pharmacology|July 24, 2024
Therapeutic targeting of voltage-gated sodium channel NaV1.7 for cancer metastasisPiyasuda Pukkanasut, Renata Jaskula-Sztul, Juan Carlos Gomora, et al.
The Journal of Surgical Research|May 17, 2011
Expression of the active Notch1 decreases MTC tumor growth in vivoRenata Jaskula-Sztul, Pongthep Pisarnturakit, Michael Landowski, et al.
Annals of Surgical Oncology|January 15, 2014
Hesperetin activates the Notch1 signaling cascade, causes apoptosis, and induces cellular differentiation in anaplastic thyroid cancerPriyesh N Patel, Xiao-Min Yu, Renata Jaskula-Sztul, et al.
Methods in Molecular Biology (Clifton, N.J.)|June 8, 2022
High-Throughput Analysis to Identify Activators of Notch SignalingRachael Guenter, Jacob Eide, Herbert Chen, et al.
Advances in Oto-Rhino-Laryngology|December 21, 2004
Reduced DNA repair capacity in laryngeal cancer subjects. A comparison of phenotypic and genotypic resultsMarzena Gajecka, Malgorzata Rydzanicz, Renata Jaskula-Sztul, et al.
Mutation Research|May 26, 2005
CYP1A1, CYP2D6, CYP2E1, NAT2, GSTM1 and GSTT1 polymorphisms or their combinations are associated with the increased risk of the laryngeal squamous cell carcinomaMarzena Gajecka, Malgorzata Rydzanicz, Renata Jaskula-Sztul, et al.
Cancer|September 20, 2012
Chrysin activates Notch1 signaling and suppresses tumor growth of anaplastic thyroid carcinoma in vitro and in vivoXiao-Min Yu, TramAnh Phan, Priyesh N Patel, et al.
Toxicology and Applied Pharmacology|November 14, 2003
Bone marrow cytotoxicity of benzo[a]pyrene is dependent on CYP1B1 but is diminished by Ah receptor-mediated induction of CYP1A1 in liverNoé Galván, Renata Jaskula-Sztul, Peter S MacWilliams, et al.
Pageof 6